TheraSphere (yttrium 90 microspheres) / Boston Scientific |
NCT01556282: TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis |
|
|
| Completed | N/A | 35 | US | TheraSphere, There are no other names for this device. | Emory University | Liver Cancer, Portal Vein Thrombosis | 01/14 | 01/14 | | |
NCT00589030: Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
|
|
| No Longer Available | N/A | | US | brachytherapy, yttrium Y 90 glass microspheres | City of Hope Medical Center | Liver Cancer | 09/14 | 09/14 | | |
NCT00701168: Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer |
|
|
| No Longer Available | N/A | | US | yttrium Y 90 microspheres (Therasphere®) | Leo W. Jenkins Cancer Center | Carcinoma, Hepatocellular, Neoplasm Metastasis | | | | |